T1	Outcomes 1264 1320	5-year survival rate and the 5-year recurrence-free rate
T2	Outcomes 1552 1575	recurrence-free period.
T3	Outcomes 1659 1708	peripheral leukocytes and peripheral lymphocytes;
T4	Outcomes 1766 1800	Inhibition of bone marrow function